(Q46952304)

26 December 2017

title

Metabolic syndrome and type 2 diabetes: lipid and physiological consequences (English)

1 reference

26 December 2017

0 references

1 reference

M John Chapman

1

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

26 December 2017

Diabetes and Vascular Disease Research

published in

1 reference

26 December 2017

volume

4 Suppl 3

1 reference

26 December 2017

page(s)

S5-8

1 reference

26 December 2017

Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Antiatherogenic small, dense HDL--guardian angel of the arterial wall?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

Renin-angiotensin system and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.050

21 January 2018

Identifiers

DOI

10.3132/DVDR.2007.050

1 reference

26 December 2017

1 reference

26 December 2017